
|Videos|January 10, 2015
How Hepatitis C Therapies are Changing Patient Treatment
Eric Tichy, PharmD, BCPS, FCCP, senior clinical pharmacy specialist at Yale New-Haven Hospital, explains how hepatitis C therapies are changing patient treatment.
Advertisement
Eric Tichy, PharmD, BCPS, FCCP, senior clinical pharmacy specialist at Yale New-Haven Hospital, explains how hepatitis C therapies are changing patient treatment.
This interview was recorded at the ASHP 2014 Midyear Clinical Meeting in Anaheim, California.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
'Beyond Weight Loss': Emerging Studies Show How GLP-1 Receptor Agonists May Impact Addiction Behaviors
2
New Drug Approach Targets KRAS-Mutant Lung Cancer to Overcome Therapy Resistance
3
FDA Approves Denosumab Biosimilars Boncresa and Oziltus for Osteoporosis-, Cancer-Related Bone Loss
4
The Role of the Pharmacist in the Management of Psychosis in Parkinson’s Disease
5










































































































































































































